LIDR

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of AEye, Inc. (LIDR) and CF Finance Acquisition Corp. III (CFAC)

Retrieved on: 
Thursday, February 22, 2024

To learn more about the action and your rights, go to:

Key Points: 
  • To learn more about the action and your rights, go to:
    or contact Joseph E. Levi, Esq.
  • either via email at [email protected] or by telephone at (212) 363-7500.
  • The LIDR merger investigation concerns whether AEye, Inc. and CF Finance Acquisition Corp. III, and the Board of LIDR have harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.
  • Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington, D.C.

University of Missouri Laboratory for Infectious Disease Study Finds Technology Used in Widely Deployed Fingerprint Scanners Kills The Virus that Causes COVID-19

Retrieved on: 
Tuesday, May 9, 2023

COLUMBIA, Mo., May 9, 2023 /PRNewswire/ -- Researchers at the University of Missouri Laboratory for Infectious Disease Research (LIDR) today released the results of a study indicating that electroluminescent (EL) film technology, found in widely deployed biometric fingerprint scanners, actively kills SARS-CoV-2 (coronavirus). Biometric fingerprint scanners are used for identification at borders, airports, arenas, and other public facilities. The study, conducted by Drs. Paul Anderson and Jeffrey Whyte at the University of Missouri Laboratory for Infectious Disease Research, should help to alleviate public fear of contracting COVID-19 via fingerprint scanners. 

Key Points: 
  • COLUMBIA, Mo., May 9, 2023 /PRNewswire/ -- Researchers at the University of Missouri Laboratory for Infectious Disease Research (LIDR) today released the results of a study indicating that electroluminescent (EL) film technology, found in widely deployed biometric fingerprint scanners, actively kills SARS-CoV-2 (coronavirus).
  • Biometric fingerprint scanners are used for identification at borders, airports, arenas, and other public facilities.
  • Paul Anderson and Jeffrey Whyte at the University of Missouri Laboratory for Infectious Disease Research, should help to alleviate public fear of contracting COVID-19 via fingerprint scanners.
  • The University of Missouri study, which examined transmission of live samples of SARS-CoV-2, revealed that the EL-based technology used in fingerprint scanners actively kills the coronavirus through the electric field created during the collection process.

AEye Reports Fourth Quarter and Full Year 2021 Results

Retrieved on: 
Monday, March 28, 2022

AEye, Inc. (Nasdaq: LIDR), the global leader in adaptive, high-performance lidar solutions, today announced its results for the fourth quarter and full year ended December 31, 2021.

Key Points: 
  • AEye, Inc. (Nasdaq: LIDR), the global leader in adaptive, high-performance lidar solutions, today announced its results for the fourth quarter and full year ended December 31, 2021.
  • In alignment with AEye CEO Blair LaCorte's article in Forbes on software-defined vehicles , AEye is enabling foundational over-the-air (OTA) update capabilities across all products.
  • ADAS: AEye transitioned initial production of automotive B-samples of AEye-based long-range lidar sensors to a Continental manufacturing line.
  • AEye management will hold a conference call today, March 28, 2021, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time) to discuss these results.

AEye Announces Common Stock Purchase Agreement With Tumim Stone Capital for up to $125 Million

Retrieved on: 
Wednesday, December 8, 2021

AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance LiDAR solutions, today announced that it has entered into a common stock purchase agreement (the Purchase Agreement) with Tumim Stone Capital LLC (Tumim Stone).

Key Points: 
  • AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance LiDAR solutions, today announced that it has entered into a common stock purchase agreement (the Purchase Agreement) with Tumim Stone Capital LLC (Tumim Stone).
  • Under the terms and subject to the conditions of the Purchase Agreement, AEye will have the right, but not the obligation, to issue and sell to Tumim Stone up to $125 million of AEyes common stock from time-to-time over the approximately 36-month term of the Purchase Agreement.
  • Under the terms of the Purchase Agreement, AEye has the right, but not the obligation, to sell to Tumim Stone up to $125 million of its common stock, subject to certain conditions.
  • As consideration for Tumim Stones commitment to purchase shares of AEyes common stock upon the terms and conditions set forth in the Purchase Agreement, AEye will issue 302,634 shares of its common stock to Tumim Stone.

Taiwania Capital Accelerates Its Efforts in Connecting International Technologies and Capital

Retrieved on: 
Thursday, September 23, 2021

With two investment arms focusing on Tech and BioTech respectively, Taiwania Capital has a combined AUM of US$490 million across four total funds.

Key Points: 
  • With two investment arms focusing on Tech and BioTech respectively, Taiwania Capital has a combined AUM of US$490 million across four total funds.
  • Taiwania Capital has been a lead investor in several overseas investments, and its rigorous due diligence procedure is recognized by internationally renowned venture capital.
  • At the end of 2018, Taiwania Capital led the Series B fundraising of AEye, partnering with international V.C.
  • Looking forward, Taiwania Capital plans to accelerate and expand its cooperation with international investors to nurture the broader startups and innovation ecosystem.